Academic literature on the topic 'Toxic Epidermal Necrolysis(TEN)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Toxic Epidermal Necrolysis(TEN).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Toxic Epidermal Necrolysis(TEN)"

1

Hoetzenecker, Wolfram, Tarun Mehra, Ieva Saulite, et al. "Toxic epidermal necrolysis." F1000Research 5 (May 20, 2016): 951. http://dx.doi.org/10.12688/f1000research.7574.1.

Full text
Abstract:
Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortality rate of approximately 30%. The clinical hallmark of TEN is a marked skin detachment caused by extensive keratinocyte cell death associated with mucosal involvement. The exact pathogenic mechanism of TEN is still uncertain. Recent advances in this field have led to the identification of several factors that might contribute to the induction of excessive apoptosis of keratinocytes. In addition, specific human leukocyte antigen types seem to be associated with certain drugs and the development
APA, Harvard, Vancouver, ISO, and other styles
2

Arun, Karmakar*1 T. Jeetenkumar Singh2 Habung Mobing3 &. P. Dhileeban Maharajan4. "NIMORZAOLE ASSOCIATED TOXIC EPIDERMAL NECROLYSIS- A CASE REPORT." Indian Journal of Medical Research and Pharmaceutical Sciences 5, no. 3 (2018): 1–3. https://doi.org/10.5281/zenodo.1193972.

Full text
Abstract:
Toxic epidermal necrolysis is a dermatological emergency. Mostly caused by Sulfonamides or NSAIDs. Nimorazole associated toxic epidermal necrolysis is rare. We present here an unusual case of toxic epidermal necrolysis caused by Nimorazole
APA, Harvard, Vancouver, ISO, and other styles
3

Sahin, Mustafa Turhan, Serap Ozturkcan, Isil Inanir, and Elif E. Filiz. "Norfloxacin-Induced Toxic Epidermal Necrolysis." Annals of Pharmacotherapy 39, no. 4 (2005): 768–70. http://dx.doi.org/10.1345/aph.1e530.

Full text
Abstract:
OBJECTIVE: To report a case of toxic epidermal necrolysis (TEN) in a man who was treated with oral norfloxacin for prostatitis. CASE SUMMARY: A 40-year-old man presented with a severe skin reaction, which was diagnosed as TEN. He had received norfloxacin 800 mg/day over a 14-day period for prostatitis and, 10 days after finishing the treatment regimen, he developed cutaneous and mucous lesions typical of TEN. After a prolonged hospitalization and treatment with oral prednisolone therapy, fluid resuscitation, and wound dressing, the man recovered. DISCUSSION: TEN is an infrequent, yet often fat
APA, Harvard, Vancouver, ISO, and other styles
4

Artymowicz, Richard J., Arthur L. Childs, and Lawrence Paolini. "Phenolphthalein-Induced Toxic Epidermal Necrolysis." Annals of Pharmacotherapy 31, no. 10 (1997): 1157–59. http://dx.doi.org/10.1177/106002809703101008.

Full text
Abstract:
OBJECTIVE: To report a case of phenolphthalein-induced toxic epidermal necrolysis (TEN) in a patient maintained on several other medications more commonly known to be associated with TEN. CASE SUMMARY: A 78-year-old white man presented with intractable lower back pain and constipation. On day 1 of admission, the patient exhibited a diffuse urticarial rash over his trunk and extremities. History revealed that the patient had taken a combination phenolphthalein/docusate sodium (Correctol) over-the-counter laxative 1 day prior to admission. He had a similar urticarial rash 1.5 years earlier with
APA, Harvard, Vancouver, ISO, and other styles
5

Som, Shubhayu, Tapas Bera, and Lopamudra (Dhar) Chowdhury. "Toxic Epidermal Necrolysis by Lamotrigine - A Case Report of Fatality." International Journal of Science and Healthcare Research 9, no. 2 (2024): 228–30. http://dx.doi.org/10.52403/ijshr.20240232.

Full text
Abstract:
Toxic epidermal necrolysis (TEN) is an immune mediated fatal adverse muco-cutaneous drug reaction characterized by extensive exfoliation of the epidermis and mucous membrane. It may result in sepsis and death. In most cases, TEN is caused by certain drugs & vaccines. TEN involves more than 30% of body surface area. Steven Johnson Syndrome also shows the same disease process and same spectrum of drug-induced epidermolysis. A 37-year-old patient who was on Lamotrigine, Escitalopram & Clonazepam for multiple somatoform disorder developed generalized vesicular rash with fever after 2 weeks
APA, Harvard, Vancouver, ISO, and other styles
6

Moshfeghi, Mersedeh, and Hilary D. Mandler. "Ciprofloxacin-Induced Toxic Epidermal Necrolysis." Annals of Pharmacotherapy 27, no. 12 (1993): 1467–69. http://dx.doi.org/10.1177/106002809302701212.

Full text
Abstract:
OBJECTIVE: To report a case of probable ciprofloxacin-induced toxic epidermal necrolysis (TEN) in an adult with systemic lupus erythematosus (SLE). CASE SUMMARY: A 31-year-old woman with SLE developed a pruritic rash following her first dose of oral ciprofloxacin. She continued taking ciprofloxacin, and the rash progressively worsened, becoming painful and covering her entire body. She discontinued the ciprofloxacin six days later and presented to the hospital, where two days later, her rash began to desquamate with epidermal erosions and a positive Nikolsky's sign. Skin biopsy was positive fo
APA, Harvard, Vancouver, ISO, and other styles
7

MOCKENHAUPT, M. "Nosology of toxic epidermal necrolysis (TEN)." Journal of the European Academy of Dermatology and Venereology 11 (September 1998): S48. http://dx.doi.org/10.1016/s0926-9959(98)94721-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sehgal, Virendra N., and Govind Srivastava. "Toxic epidermal necrolysis (TEN) Lyell's syndrome." Journal of Dermatological Treatment 16, no. 5-6 (2005): 278–86. http://dx.doi.org/10.1080/09546630500375684.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Datta, Ananda, Raghavendrun Sivasankar, and Bikash Ranjan Kar. "Pyrazinamide-induced Toxic Epidermal Necrolysis." Annals of African Medicine 23, no. 3 (2024): 494–95. http://dx.doi.org/10.4103/aam.aam_161_23.

Full text
Abstract:
The antitubercular drugs are associated with different cutaneous adverse drug reactions. Toxic epidermal necrolysis (TEN) is a severe form of cutaneous reaction. Although it is rare, it carries a high mortality rate. We report a case of a 75-year-old man with abdominal tuberculosis, who developed pyrazinamide-induced TEN.
APA, Harvard, Vancouver, ISO, and other styles
10

Poulsen, Viktoria Oline Barrios, Jonas Nielsen, and Troels Dirch Poulsen. "Rapidly Developing Toxic Epidermal Necrolysis." Case Reports in Emergency Medicine 2013 (2013): 1–4. http://dx.doi.org/10.1155/2013/985951.

Full text
Abstract:
Severe cutaneous reactions with potentially fatal outcomes can have many different causes. The Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare. They are characterized by a low incidence but high mortality, and drugs are most commonly implicated. Urgent active therapy is required. Prompt recognition and withdrawal of suspect drug and rapid intervention can result in favourable outcome. No further international guidelines for treatment exist, and much of the treatment relies on old or experimental concepts with no scientific evidence. We report on a 54-year-old man e
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Toxic Epidermal Necrolysis(TEN)"

1

Cooper, Ryan. "Intravenous Immunoglobulin Use in the Treatment of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome: A 10-year Retrospective Analysis of Patients of a Single Burn Center." Thesis, The University of Arizona, 2014. http://hdl.handle.net/10150/315845.

Full text
Abstract:
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine.<br>Stevens - Johnson syndrome and Toxic Epidermal Necrolysis Syndrome are rare, but serious conditions affecting skin and mucous membranes that are primarily treated with supportive care. Other more specific therapies have limited evidence to support the benefit of their use; one such treatment is intravenous immunoglobulin (IVIG). The use of IVIG in the treatment of these syndromes remain controversial due to mixed results demonstrated
APA, Harvard, Vancouver, ISO, and other styles
2

Van, Zyl Lourens Marthinus. "Prevalence of chronic ocular complications in Stevens-Johnson Syndrome and toxic epidermal necrolysis." Master's thesis, University of Cape Town, 2013. http://hdl.handle.net/11427/2899.

Full text
Abstract:
Includes abstract.<br>Includes bibliographical references.<br>The main objective of the study is to identify and grade the severity of chronic ocular complications in patients who were treated for SJS and TEN at Groote Schuur Hospital. The secondary objective is to identify patients who need referrals to specialist ophthalmic clinics for treatable ocular complications of SJS and TEN.
APA, Harvard, Vancouver, ISO, and other styles
3

Poletti, Jabbour Jamil, Rospigliosi Andrés Wiegering, Elías Reneé Pereyra, and Barrera Carmen Cecilia Elías. "Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap." Springer International Publishing, 2016. http://hdl.handle.net/10757/609483.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Villani, Axel. "Rôle des lymphocytes T CD8+ dans les hypersensibilités retardées cutanées médicamenteuses." Thesis, Lyon, 2019. http://www.theses.fr/2019LYSE1143.

Full text
Abstract:
La nécrolyse épidermique toxique (NET) est une réaction cutanée médicamenteuse (CADR - Cutaneous Adverse Drug Reaction) rare et sévère qui se caractérise par une nécrose brutale de l’épiderme, entraînant un décollement cutané plus ou moins étendu. Il s’agit d’une urgence vitale avec jusqu’à 30% de décès à la phase aiguë. L’importance de la surface décollée définit deux entités cliniques : le syndrome de Stevens-Johnson quand le décollement est inférieur à 10% et le syndrome de Lyell quand il est supérieur à 30%. A distance, le risque de complications, notamment sous forme de synéchies des muqu
APA, Harvard, Vancouver, ISO, and other styles
5

Villani, Axel. "Rôle des lymphocytes T CD8+ dans les hypersensibilités retardées cutanées médicamenteuses." Electronic Thesis or Diss., Lyon, 2019. http://www.theses.fr/2019LYSE1143.

Full text
Abstract:
La nécrolyse épidermique toxique (NET) est une réaction cutanée médicamenteuse (CADR - Cutaneous Adverse Drug Reaction) rare et sévère qui se caractérise par une nécrose brutale de l’épiderme, entraînant un décollement cutané plus ou moins étendu. Il s’agit d’une urgence vitale avec jusqu’à 30% de décès à la phase aiguë. L’importance de la surface décollée définit deux entités cliniques : le syndrome de Stevens-Johnson quand le décollement est inférieur à 10% et le syndrome de Lyell quand il est supérieur à 30%. A distance, le risque de complications, notamment sous forme de synéchies des muqu
APA, Harvard, Vancouver, ISO, and other styles
6

Wei, Chun-Yu, and 魏淳郁. "Pathological role of HLA-B*1502 in carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis." Thesis, 2012. http://ndltd.ncl.edu.tw/handle/53019387631640777046.

Full text
Abstract:
博士<br>國立陽明大學<br>生化暨分子生物研究所<br>100<br>Increasing studies revealed that HLA alleles are the major genetic determinants of drug hypersensitivity; however, the underlying molecular mechanism remains unclear. Here, we adopt the HLA-B*1502 genetic predisposition to carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) as a model to study the pathological role of HLA in delayed-type drug hypersensitivity. We in vitro expanded CBZ-specific cytotoxic T lymphocytes (CTLs) from CBZ-SJS/TEN patients and analyzed the interaction between HLA-B and CBZ/analogs by CTLs re
APA, Harvard, Vancouver, ISO, and other styles
7

Pintar, David. "Netermické ztráty kožního krytu na Klinice popáleninové medicíny za roky 1998 - 2008." Master's thesis, 2010. http://www.nusl.cz/ntk/nusl-280937.

Full text
Abstract:
Exfoliative loses of the skin are rare, but potentially lethal disorders that includes toxical epidermal necrolysis and staphylococcal scalded skin syndrome. They should be considered in a differential diagnosis and a quick transfer to the burn center is essential. The level of care and the effectiveness of the treatment at the burn unit significantly decreases the morbidity and mortality of these diseases. A transport of the patient proceeds with a time delay and the usage of the systemic corticosteroids at the previous hospital unit is frequent, according to the results of our clinical study
APA, Harvard, Vancouver, ISO, and other styles
8

Freitas, Daniel Vilaverde. "Síndrome Stevens-Johnson / Necrólise Epidérmica Tóxica - foco na fisiopatologia e tratamento." Master's thesis, 2018. http://hdl.handle.net/10316/82801.

Full text
Abstract:
Trabalho Final do Mestrado Integrado em Medicina apresentado à Faculdade de Medicina<br>Stevens-Johnson syndrome and toxic epidermal necrolysis are part of a spectrum of rare but acute and potentially life-threatening mucocutaneous reactions. The vast majority of cases are caused by medication, with allopurinol, non-steroidal anti-inflammatory drugs, antibiotics and anticonvulsants as the most frequently involved drugs. Generally, the reaction occurs within 7-21 days of the onset of drug administration.The main manifestation of SJS/TEN is a painful erythema with extensive exfoliation of the ep
APA, Harvard, Vancouver, ISO, and other styles
9

Oliveira, Ana Rita de Jesus. "Caracterização de Reações de Hipersensibilidade a Medicamentos." Master's thesis, 2017. http://hdl.handle.net/10316/83651.

Full text
Abstract:
Relatório de Estágio do Mestrado Integrado em Ciências Farmacêuticas apresentado à Faculdade de Farmácia<br>A base da intervenção médica é a utilização de medicamentos que estão muitas vezes associados a complicações inerentes ao seu uso, sendo uma das principais causas da ocorrência de eventos adversos nos cuidados de saúde.A definição de RAM é vaga. Deve esclarecer-se que não são resultantes apenas da “utilização autorizada de um medicamento em doses normais, mas também dos erros terapêuticos e das utilizações fora dos termos da autorização de introdução no mercado, incluindo a utilização in
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Toxic Epidermal Necrolysis(TEN)"

1

Deguine, Hervé. Rwanda : enquête sur la mort d'André Sibomana. Reporters sans frontières, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dancing after TEN. Fantagraphics Books, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Piérard, Gérald E., Claudine Franchimont, Serge Jennes, and Philippe Paquet. Conundrum of Toxic Epidermal Necrolysis. Nova Science Publishers, Incorporated, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jolly, Elaine, Andrew Fry, and Afzal Chaudhry, eds. Dermatology. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199230457.003.0006.

Full text
Abstract:
Chapter 6 covers the basic science and clinical topics relating to dermatology which trainees are required to learn as part of their basic training and demonstrate in the MRCP. It covers eczema/dermatitis, psoriasis, blistering skin disorders, bacterial and viral infections of the skin, fungal infections and infestations, erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis, erythema nodosum, drug eruptions, benign skin tumours, malignant skin tumours, the skin and systemic disease, cutaneous lupus erythematosus, systemic sclerosis (scleroderma), vasculitis, structure and f
APA, Harvard, Vancouver, ISO, and other styles
5

Groves, Richard. Assessment and management of dermatological problems in the critically ill. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0276.

Full text
Abstract:
Although dermatology is generally considered to be an outpatient specialty relating to conditions of low acuity, a wide array of skin problems can present in the critically-ill patient. Some may reflect pre-existing disease, some may occur as a consequence of treatment, and a small fraction will represent severe or extensive primary skin disease that is best managed in a critical care setting. Important primary dermatological conditions that require intensive care management include erythroderma, toxic epidermal necrolysis/Stevens–Johnson syndrome, widespread drug eruptions and blistering diso
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Toxic Epidermal Necrolysis(TEN)"

1

Obeid, Grace, Laurence Valeyrie-Allanore, and Pierre Wolkenstein. "Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS)." In European Handbook of Dermatological Treatments. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45139-7_98.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zimmerman, Danielle, and Nam Hoang Dang. "Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)." In Oncologic Critical Care. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-74698-2_195-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zimmerman, Danielle, and Nam Hoang Dang. "Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)." In Oncologic Critical Care. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-74588-6_195.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chronopoulos, Argyrios, Maja Mockenhaupt, and Uwe Pleyer. "Okuläre Beteiligung bei und Toxisch epidermaler Nekrolyse (engl. Stevens-Johnson syndrome, SJS, and toxic epidermal necrolysis, TEN)." In Entzündliche Augenerkrankungen. Springer Berlin Heidelberg, 2021. http://dx.doi.org/10.1007/978-3-662-60399-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fry, Lionel, Fenella T. Wojnarowska, and Parvin Shahrad. "Toxic Epidermal Necrolysis." In Illustrated Encyclopedia of Dermatology. Springer Netherlands, 1985. http://dx.doi.org/10.1007/978-94-010-9390-3_50.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Crowe, David R. "Toxic Epidermal Necrolysis." In Deadly Dermatologic Diseases. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-31566-9_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Minas, A. "Toxic Epidermal Necrolysis." In European Handbook of Dermatological Treatments. Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-662-03835-2_100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Inai, Kei, Alexander K. C. Leung, Jouni Uitto, et al. "Epidermal Necrolysis, Toxic." In Encyclopedia of Molecular Mechanisms of Disease. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_584.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Raj, Satish R., S. R. Wayne Chen, Robert S. Sheldon, et al. "Toxic Epidermal Necrolysis." In Encyclopedia of Molecular Mechanisms of Disease. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_9374.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gammanpila, Ranthilaka R., and Eckart Haneke. "Toxic epidermal necrolysis." In Dermatoses in Dark Vs Light Skin. CRC Press, 2025. https://doi.org/10.1201/9781003479512-121.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Toxic Epidermal Necrolysis(TEN)"

1

Gillis, Nancy K., Gillian C. Bell, Howard L. McLeod, and Amy J. Brandt. "Abstract 4304: Prevalence and triggers of drug-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in a cancer patient cohort." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-4304.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Irfanti, Rakhma Tri, Ummi Rinandari, and Harijono Kariosentono. "Systemic Corticosteroid Therapy for Steven Johnson Syndrome (SJS): Toxic Epidermal Necrolysis (TEN) Inhospitalized Patients of Dr. Moewardigeneral Hospital Surakarta January 2016-December 2017." In The 23rd Regional Conference of Dermatology 2018. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008149800180022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ribeiro Araujo Carneiro de Lucena, Germana, Edgard Torres dos Reis Neto, Igor Beltrão Duarte Fernandes, Milvia Maria Simões e Silva Enokihara, and Daniel Viana da Silva e Silva. "TOXIC EPIDERMAL NECROLYSIS IN A SYSTEMIC LUPUS ERYTHEMATOSUS PATIENT." In Congresso Brasileiro de Reumatologia 2020. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2020.17326.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pasini, Briane Alcântara Vieira, Joaquim Ivo Vasques Dantas Landim, André Silva Franco, Ana Paula Luppino Assad, Nadia Emi Aikawa, and Claudia Goldenstein Schainberg. "TOXIC EPIDERMAL NECROLYSIS-LIKE ACUTE CUTANEOUS LUPUS A CASE REPORT." In XLI Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2024. https://doi.org/10.47660/cbr.2024.2173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Egan, A., and C. E. Daniels. "A Denuding Drug: A Case of Methotrexate-Induced Toxic Epidermal Necrolysis." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4853.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cerro Chiang, G. C., and O. K. Rojanapairat. "Toxic Epidermal Necrolysis Presenting With Disseminated Intravascular Coagulopathy and Multiorgan Failure." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a5174.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Carbinatto, Rebeca Barbosa, Lucas Eduardo Pedri, Marina de Sousa Vieira, et al. "TOXIC EPIDERMAL NECROLYSIS-LIKE AS THE FIRST MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS." In XL Congresso Brasileiro de Reumatologia. Sociedade Brasileiro de Reumatologia, 2023. http://dx.doi.org/10.47660/cbr.2023.1975.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hallami, Alyazia Al, Najla Al Kuwaiti, and Omer Yousef. "P89 Toxic epidermal necrolysis in a 4 year old girl in the UAE." In Faculty of Paediatrics of the Royal College of Physicians of Ireland, 9th Europaediatrics Congress, 13–15 June, Dublin, Ireland 2019. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2019. http://dx.doi.org/10.1136/archdischild-2019-epa.444.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chaudhary, Himanshi, Dharmagat Bhattarai, Pandiarajan Vignesh, et al. "159 Pediatric onset lupus with stevens johnson syndrome/toxic epidermal necrolysis: an unusual association." In 13th International Congress on Systemic Lupus Erythematosus (LUPUS 2019), San Francisco, California, USA, April 5–8, 2019, Abstract Presentations. Lupus Foundation of America, 2019. http://dx.doi.org/10.1136/lupus-2019-lsm.159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vieira, Mariana Ferreira, Dimona Carvalho Vivas Amado, Gessyca Bôm Ribeiro Cunha, Flavio Ribeiro Pereira, Rodrigo Lousada, and Gabriel Lisbôa Pereira. "ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS EVOLVING WITH DRUG-INDUCED TOXIC EPIDERMAL NECROLYSIS: A CASE REPORT." In XL Congresso Brasileiro de Reumatologia. Sociedade Brasileiro de Reumatologia, 2023. http://dx.doi.org/10.47660/cbr.2023.1806.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Toxic Epidermal Necrolysis(TEN)"

1

Stewart, Thomas, Hemali Shah, and John Frew. Infectious complications of Stevens Johnson syndrome and toxic epidermal necrolysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.1.0124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Stewart, Thomas, Joshua Farrell, and John Frew. Psychological complications of Stevens Johnson syndrome and toxic epidermal necrolysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.1.0097.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chee, Elyssa, Esther Hong, and Thomas Stewart. Stevens Johnson syndrome and toxic epidermal necrolysis due to topical drugs: A systematic review of case reports. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.7.0052.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Stewart, Thomas, Jeremy Chan, and John Frew. A systematic review and meta-analysis of Non-SCORTEN mortality predictors in Stevens Johnson syndrome and toxic epidermal necrolysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.4.0005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Stewart, Thomas, Nicole Seebacher, and John Frew. A systematic review and meta-analysis of case-control studies on cytokines in blister fluid and skin of patients with Stevens Johnson syndrome and toxic epidermal necrolysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.2.0123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Severe Cutaneous Adverse Reactions. A consensus by a CIOMS Working Group. CIOMS, 2025. https://doi.org/10.56759/lrty1600.

Full text
Abstract:
In clinical practice, there is mounting concern about the burden of SCAR in relation to novel biologics as well as the increasing cost of diagnosis and management. This consensus report provides unique insights and the latest thinking from renowned experts on this important topic. The skin is among the parts of the body most commonly affected by adverse drug reactions (ADRs). Cutaneous ADRs affect 2% to 3% of all hospitalized patients and have a wide spectrum of clinical manifestations, are caused by various medicinal products, and result from different pathophysiologic mechanisms. Hence, thei
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!